HemaSphere Podcast
by HemaSphere Journal
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·26 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Recent guests
Recent episodes
Why Inflammatory Signaling Holds the Key to Durable MDS Therapies - Dr Manja Wobus, Dr Katja Sockel
Jun 17, 2026
38m 29s
p53 in Cancer: Dual Threat - Dr Isabelle Plo, Dr Barbara Monte-Mór
May 7, 2026
36m 46s
Blinatumomab in De Novo AYA ALL - Dr Matthew Greenwood
Feb 9, 2026
46m 58s
Inequalities in sickle cell therapies - Dr Stephen Hibbs, Dr Paul Telfer, Mary-Shaniqua - Patient Advocate
Dec 2, 2025
55m 14s
Defining Lineage in Ambiguous Leukemia: A Transcriptomic View - Dr. Anikó Sijs-Szabó & Roger Mulet Lázaro, PhD
Nov 3, 2025
35m 42s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/17/26 | inflammatory signalingMDS therapies+3 | Dr Manja WobusDr Katja Sockel | HemaSphereEHA | — | MDStasquinimod+5 | — | 38m 29s | ||
| 5/7/26 | p53cancer+4 | Dr Isabelle PloDr Barbara Monte-Mór | HemaSphere Journalp53+4 | — | p53cancer+4 | — | 36m 46s | ||
| 2/9/26 | immunotherapyB-cell ALL+3 | Dr Matthew Greenwood | blinatumomabmenin inhibitors+3 | — | blinatumomabimmunotherapy+5 | — | 46m 58s | ||
| 12/2/25 | sickle cell diseasehealth inequalities+3 | Dr Stephen HibbsDr Paul Telfer+1 | HemaSphere JournalNICE (National Institute for Health and Care Excellence)+1 | — | sickle cell therapieshealth inequalities+3 | — | 55m 14s | ||
| 11/3/25 | acute leukemiaprecision medicine+3 | Dr. Anikó Sijs-SzabóRoger Mulet Lázaro, PhD | HemaSphere | — | leukemiatranscriptomics+5 | — | 35m 42s | ||
| 10/1/25 | CAR-T therapytoxicities+3 | Dr Kai Rejeski | HemaSphereEHA+1 | — | CAR-T therapytoxicities+5 | — | 40m 58s | ||
| 9/1/25 | NUP98 rearranged AMLpediatric oncology+3 | Prof Michel ZwaanProf Olaf Heidenreich | HemaSphereThe MLL-Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML | — | NUP98AML+5 | — | 41m 07s | ||
| 7/29/25 | metabolismhematology+4 | Prof Dr Petya ApostolovaDr Jörg Büscher | HemaSphereHemaSphere Journal+1 | — | metabolismhematology+5 | — | 28m 52s | ||
| 7/29/25 | metabolismhematology+3 | Dr Jörg BüscherProf Dr Petya Apostolova | HemaSphereHemaSphere Journal | — | metabolismhematology+5 | — | 29m 51s | ||
| 7/2/25 | machine learningacute myeloid leukemia+4 | Tim Mocking, PhD | HemaSphere JournalApplications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia | — | machine learningacute myeloid leukemia+5 | — | 29m 24s | ||
| 6/3/25 | neutropeniatreatment guidelines+3 | Dr. Francesca FioreddaDr. Eleni Papadaki | European Hematology AssociationEuNet-INNOCHRON COST Action+2 | — | neutropeniatreatment guidelines+3 | — | 28m 05s | ||
| 5/5/25 | acute lymphoblastic leukemiasingle cell sequencing+5 | Jan CoolsHeidi Segers+1 | HemaSphereHemaSphere Journal | — | acute lymphoblastic leukemiasingle cell DNA+5 | — | 34m 17s |
Showing 12 of 12
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.